Literature DB >> 25327059

Steroid resistant asthma.

S K Luhadia.   

Abstract

Inspite of very safe and effective treatment, Bronchial asthmatics do not respond well in 5-10% of cases which are labelled as Refractory Asthma. Besides compliance, presence of psychogenic and trigger factors and comorbid illness, steroid insensitiveness or resistance may play a significant role in the poorly controlled/responding asthmatics. Type I Steroid resistance is due to lack of binding affinity of steroids to glucocorticoid receptors and may respond to higher doses of steroids while type II steroid resistance is because of reduced number of cells with glucocorticoid receptors, which is very rare and do not respond to even higher doses of systemic steroids and these cases require alternative/novel therapies. Future treatment of steroid resistant and severe refractory asthma is likely to be targeted towards cytokines and Bronchial Thermoplasty.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25327059

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  4 in total

1.  Adenovirus vector-mediated YKL-40 shRNA attenuates eosinophil airway inflammation in a murine asthmatic model.

Authors:  Ling Wang; Aihua Bao; Ying Zheng; Aying Ma; Yi Wu; Huanxia Shang; Danruo Fang; Suqin Ben
Journal:  Gene Ther       Date:  2020-10-12       Impact factor: 5.250

2.  PTGDR gene expression and response to dexamethasone treatment in an in vitro model.

Authors:  Elena Marcos-Vadillo; Asunción García-Sánchez; Catalina Sanz; Ignacio Davila; María Isidoro-García
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

3.  Berberine Inhibits Pro-inflammatory Cytokine-induced IL-6 and CCL11 Production via Modulation of STAT6 Pathway in Human Bronchial Epithelial Cells.

Authors:  Jason Ma; Cheng-Chi Chan; Wen-Chung Huang; Ming-Ling Kuo
Journal:  Int J Med Sci       Date:  2020-06-08       Impact factor: 3.738

4.  Simulation Study of Interactions Between Two Bioactive Components from Zingiber cassumunar and 5-Lipoxygenase.

Authors:  Kulpavee Jitapunkul; Orapan Poachanukoon; Supa Hannongbua; Pisanu Toochinda; Luckhana Lawtrakul
Journal:  Cell Mol Bioeng       Date:  2017-11-17       Impact factor: 2.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.